Opportunistic Viral Infections, 3rd Edition

Dear Colleagues,

For many years we have been accustomed to associating certain opportunistic viral infections with HIV/AIDS infection, the pandemic still ongoing around the world that causes thousands of new infections every day and still has a high mortality and lethality rate.

AIDS has taught us a great deal about opportunistic infections due to microorganisms that are rare or in themselves often endowed with little virulence, but which multiply to become aggressive pathogens in immunocompromised individuals as a result of infections, therapies or situations leading to immunodepression. Today, however, we must not forget other opportunistic infections that arise in people who do not have HIV/AIDS, but who have frailty because they are affected by non-infectious diseases which require lengthy treatment with anti-tumor, biotechnological and chemotherapeutic drugs in general. Among these, herpesvirus, HBV, HPV, human polyoma virus 1 (BK), JC virus and some coronaviruses are just a few examples.

In the third edition of this Special Issue, we will focus on the most recent advances in opportunistic viral infections from epidemiological, diagnostic and therapeutic perspectives, with special emphasis on the immunocompromised host, the frail individual, the transplanted and the individual undergoing chemotherapy or antibody-based drugs against TNF-α blockers.

Prof. Dr. Carlo Contini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.